trending Market Intelligence /marketintelligence/en/news-insights/trending/82eGyZwX55dYJoX-SmsM7A2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Tandem Diabetes plans common stock, warrants offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Tandem Diabetes plans common stock, warrants offering

Tandem Diabetes Care Inc. plans to offer and sell its common shares, series A warrants and series B warrants to buy common shares in an underwritten public offering.

The company plans to use the net proceeds for working capital and other general corporate purposes.

Oppenheimer & Co. Inc. is acting as the sole book-running manager and National Securities Corp. is acting as a co-manager for the offering.